Ardelyx (ARDX) Debt Ratio (2018 - 2026)
Ardelyx (ARDX) posted Debt Ratio of 0.4 for Q1 2026, little changed on a QoQ basis from 0.4 in Q4 2025, and up 9.37% year-over-year from 0.37 in Q1 2025.
Ardelyx (ARDX) Debt Ratio (2018 - 2026) Analysis & Trends
Ardelyx's Debt Ratio history runs 9 years deep, the most recent figure standing at 0.4 for Q1 2026.
- Quarterly Debt Ratio rose 9.37% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (up 9.37% YoY) and the FY2025 annual result came in at 0.4, up 16.81% from the prior year.
- Debt Ratio was 0.4 for Q1 2026 at Ardelyx, roughly flat from 0.4 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.43 in Q2 2025 and bottomed at 0.09 in Q3 2023.
- A 5-year average of 0.3 and a median of 0.35 in 2024 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio tumbled 74.36% — and 2024, when it soared 190.94%.
- Ardelyx's Debt Ratio stood at 0.14 in 2022, then gained by 19.13% to 0.17 in 2023, then soared by 106.77% to 0.35 in 2024, then climbed by 16.81% to 0.4 in 2025, then dropped by 0.24% to 0.4 in 2026.
- Business Quant data shows ARDX's Debt Ratio at 0.4 in Q1 2026, 0.4 in Q4 2025, and 0.42 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.42 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.29 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.09 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.14 |
| Sep 30, 2022 | 0.37 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.40 |
| Dec 31, 2021 | 0.22 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | 0.25 |